Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5– and IMP-7–type carbapenemases in a tertiary hospital-Reference-Cited by-同舟云学术

Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5– and IMP-7–type carbapenemases in a tertiary hospital

Published:2021-01 Issue:1 Volume:99 Page:115174
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Çekin Zuhal Kalaycı,Dabos Laura,Malkoçoğlu Gülşah,Fortineau Nicolas,Bayraktar Banu,Iorga Bogdan I.,Naas Thierry,Aktaş Elif

Funder

Assistance publique-Hôpitaux de Paris

Université Paris-Saclay

Institut National de la Santé et de la Recherche Médicale

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference69 articles.

1. Intraclonal variations of resistance and phenotype in Pseudomonas aeruginosa epidemic high-risk clone ST308: a key to success within a hospital?;Abdouchakour;International Journal of Medical Microbiology,2018

2. Diversity of molecular mechanisms conferring carbapenem resistance to Pseudomonas aeruginosa isolates from Saudi Arabia;Al-Agamy;Canadian Journal of Infectious Diseases and Medical Microbiology,2016

3. Formation of an adduct between fosfomycin and glutathione: a new mechanism of antibiotic resistance in bacteria;Arca;Antimicrobial Agents and Chemotherapy,1988

4. Detection of VIM-5 metallo-β-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey;Bahar;Journal of Antimicrobial Chemotherapy,2004

5. A novel integron gene cassette harboring VIM-38 metallo-β-lactamase in a clinical Pseudomonas aeruginosa isolate;Beriş;Annals of laboratory medicine,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye;European Journal of Clinical Microbiology & Infectious Diseases;2024-07-12

2. Multi-resistance to carbapenems by the production of Imipenemase (IMP)-types carbapenemases in Gram-negative bacilli in Burkina Faso;African Journal of Biotechnology;2024-02-29

3. Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant Pseudomonas aeruginosa Clinical Strains: A Challenge for Tertiary Care Hospitals;Antibiotics;2024-02-16

4. Evaluation of ceftazidime-avibactam susceptibility in carbapenem resistant Klebsiella pneumoniae and Pseudomonas aeruginosa isolates;Journal of Medicine and Palliative Care;2023-12-31

5. Acquired blaVIM and blaGES Carbapenemase-Encoding Genes in Pseudomonas aeruginosa: A Seven-Year Survey Highlighting an Increasing Epidemiological Threat;Pathogens;2023-10-18